Little Journey, a healthtech company providing personalized psychological support for pediatric care, has secured £6 million in Series A funding led by Par Equity, with participation from Mercia Ventures, Northern Powerhouse Investment Fund, Octopus Ventures, Calm/Storm Ventures, and angel investors.
“Securing this investment allows us to scale our impact across healthcare and life sciences, with a focus on easing the burden of paediatric clinical trials,” said Chris Evans, Co-Founder & CEO of Little Journey. “While legislation like RACE, SPCs, and the ODA has increased study numbers, specialist paediatric knowledge is still lacking in the industry. This has led to lower recruitment, adherence and trial completion rates compared to adult research. Little Journey is uniquely positioned to fill this expertise gap and tackle these challenges to advance global paediatric medicine.”
The company, founded in 2018 by Dr. Chris Evans and Sophie Copley, has developed an app supporting children through medical procedures. Currently used in over 100 hospitals across 11 countries with content in 20 languages, the platform supports children through various procedures including MRI, mental health assessments, and blood tests.
“We’re ready to take our product capabilities to the next level. Little Journey already tailors support based on age, language, procedure, and trial protocol,” said Sophie Copley, Co-Founder & CPO. “With this Series A funding, we will enhance our data capabilities and further globalise our offering, enabling a data-driven, personalised model of care in paediatrics. This will drive impact for our growing international customer base in a patient-centric way. By empowering families with the right knowledge and resources at the right time, we believe we can help build a brighter, healthier future for all children across the globe.”
“Healthtech is at the heart of what we do at Par Equity. We are committed to supporting high-growth, impactful health tech companies that have the potential to revolutionise the way that care is delivered,” said Elizabeth Young, Investment Manager at Par Equity. “At present, there exists a pressing need for bespoke technologies tailored to children and Little Journey’s innovative approach to paediatric care does just that.”
The funding will support global expansion, particularly in the US market, and fund product enhancements including scalable content and data collection capabilities. The company has also secured additional grant funding of £2.09 million from the LEGO Foundation’s Play for All Accelerator and £493,000 from SBRI Healthcare for enhancing app accessibility for children with disabilities.
